<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01364194</url>
  </required_header>
  <id_info>
    <org_study_id>516/2552(EC3)</org_study_id>
    <nct_id>NCT01364194</nct_id>
  </id_info>
  <brief_title>Local Infiltration With Bupivacaine to Increase Quality of Post-operative Pain Control in Total Knee Replacement</brief_title>
  <official_title>Periarticular Injection With Bupivacaine For Post-Operative Pain Control In Total Knee Replacement: A Prospective Randomized Double-Blind Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mahidol University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Siriraj Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Mahidol University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the efficacy of periarticular injection with 0.25%
      bupivacaine for controlling pain after total knee replacement to improve the quality of
      post-operative care.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Compare post operative pain control after total knee replacement by periarticular injection
      with 0.25% bupivacaine compare with 0.9% normal saline.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2010</start_date>
  <completion_date type="Actual">September 2010</completion_date>
  <primary_completion_date type="Actual">September 2010</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Post operative pain</measure>
    <time_frame>96 hour post operation</time_frame>
    <description>Measure by Visual analog scale scores and morphine consumption</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Complication of Morphine consumption</measure>
    <time_frame>96 hour post operation</time_frame>
    <description>nausea, pruritis, urinary retention and constipation</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Pain, Postoperative</condition>
  <condition>Arthropathy of Knee Joint</condition>
  <arm_group>
    <arm_group_label>0.25% Bupivacaine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Periarticular injection with 20 ml of 0.25% bupivacaine before wound closure.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>0.9% normal saline</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Periarticular injection with 20 ml of 0.9% normal saline before wound closure.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>0.25% Bupivacaine</intervention_name>
    <description>Periarticular injection with 20 ml of 0.25% bupivacaine before wound closure.</description>
    <arm_group_label>0.25% Bupivacaine</arm_group_label>
    <other_name>Marcaine</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>0.9% normal saline</intervention_name>
    <description>Periarticular injection with 20 ml of 0.9% normal saline before wound closure.</description>
    <arm_group_label>0.9% normal saline</arm_group_label>
    <other_name>Isotonic saline</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  primary osteoarthritis patients undergoing total knee replacement at Siriraj Hospital

          -  BMI between 20-35

          -  having a full understanding of the question in this trial

        Exclusion Criteria:

          -  allergy to NSAIDs, Acetaminophen, Bupivacaine

          -  blood creatinine more than 1.5 mg/dl or creatinine clearance less than 60 mL/min

          -  abnormal liver function

          -  previous surgery on the knee undergoing total knee replacement

          -  patient could not receive spinal anesthesia
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Keerati Chareancholvanich, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Siriraj Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Siriraj Hospital</name>
      <address>
        <city>Bangkoknoi</city>
        <state>Bangkok</state>
        <zip>10700</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Thailand</country>
  </location_countries>
  <link>
    <url>http://www.nlm.nih.gov/medlineplus/kneereplacement.html</url>
    <description>Total knee replacement</description>
  </link>
  <link>
    <url>http://www.rxlist.com/marcaine-drug.htm</url>
    <description>Bupivacaine information</description>
  </link>
  <reference>
    <citation>Mehrotra C, Remington PL, Naimi TS, Washington W, Miller R. Trends in total knee replacement surgeries and implications for public health, 1990-2000. Public Health Rep. 2005 May-Jun;120(3):278-82.</citation>
    <PMID>16134568</PMID>
  </reference>
  <reference>
    <citation>Akyol O, Karayurt O, Salmond S. Experiences of pain and satisfaction with pain management in patients undergoing total knee replacement. Orthop Nurs. 2009 Mar-Apr;28(2):79-85. doi: 10.1097/NOR.0b013e3181945f62.</citation>
    <PMID>19339865</PMID>
  </reference>
  <reference>
    <citation>Singelyn FJ, Deyaert M, Joris D, Pendeville E, Gouverneur JM. Effects of intravenous patient-controlled analgesia with morphine, continuous epidural analgesia, and continuous three-in-one block on postoperative pain and knee rehabilitation after unilateral total knee arthroplasty. Anesth Analg. 1998 Jul;87(1):88-92.</citation>
    <PMID>9661552</PMID>
  </reference>
  <reference>
    <citation>Toftdahl K, Nikolajsen L, Haraldsted V, Madsen F, Tønnesen EK, Søballe K. Comparison of peri- and intraarticular analgesia with femoral nerve block after total knee arthroplasty: a randomized clinical trial. Acta Orthop. 2007 Apr;78(2):172-9.</citation>
    <PMID>17464603</PMID>
  </reference>
  <reference>
    <citation>Vendittoli PA, Makinen P, Drolet P, Lavigne M, Fallaha M, Guertin MC, Varin F. A multimodal analgesia protocol for total knee arthroplasty. A randomized, controlled study. J Bone Joint Surg Am. 2006 Feb;88(2):282-9.</citation>
    <PMID>16452738</PMID>
  </reference>
  <reference>
    <citation>Parvataneni HK, Shah VP, Howard H, Cole N, Ranawat AS, Ranawat CS. Controlling pain after total hip and knee arthroplasty using a multimodal protocol with local periarticular injections: a prospective randomized study. J Arthroplasty. 2007 Sep;22(6 Suppl 2):33-8. Epub 2007 Jul 26.</citation>
    <PMID>17823012</PMID>
  </reference>
  <reference>
    <citation>Busch CA, Shore BJ, Bhandari R, Ganapathy S, MacDonald SJ, Bourne RB, Rorabeck CH, McCalden RW. Efficacy of periarticular multimodal drug injection in total knee arthroplasty. A randomized trial. J Bone Joint Surg Am. 2006 May;88(5):959-63.</citation>
    <PMID>16651569</PMID>
  </reference>
  <verification_date>May 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 31, 2011</study_first_submitted>
  <study_first_submitted_qc>June 1, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 2, 2011</study_first_posted>
  <last_update_submitted>June 1, 2011</last_update_submitted>
  <last_update_submitted_qc>June 1, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 2, 2011</last_update_posted>
  <responsible_party>
    <name_title>Keerati Chareancholvanich, MD</name_title>
    <organization>Siriraj Hospital, Mahidol University</organization>
  </responsible_party>
  <keyword>Post operative pain</keyword>
  <keyword>Total knee replacement</keyword>
  <keyword>Total knee arthroplasty</keyword>
  <keyword>Bupivacaine</keyword>
  <keyword>Periarticular injection</keyword>
  <keyword>Placebo</keyword>
  <keyword>Morphine consumption</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
    <mesh_term>Joint Diseases</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bupivacaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

